scholarly journals NS 1 lasts longer than the dengue virus nucleic acid in the clinically suspected patients with dengue fever and dengue haemorrhagic fever

VirusDisease ◽  
2017 ◽  
Vol 28 (3) ◽  
pp. 341-344 ◽  
Author(s):  
Nadeera Sirisena ◽  
Faseeha Noordeen ◽  
LakKumar Fernando
Keyword(s):  
Nucleic Acid ◽  
Dengue Virus ◽  
Dengue Fever ◽  
Dengue Haemorrhagic Fever ◽  
Haemorrhagic Fever

Headache Features in Patients with Dengue Virus Infection

Cephalalgia ◽  
2006 ◽  
Vol 26 (7) ◽  
pp. 879-882 ◽  
Author(s):  
RB Domingues ◽  
GW Kuster ◽  
FL Onuki de Castro ◽  
VA Souza ◽  
JE Levi ◽  
...  
Keyword(s):  
Virus Infection ◽  
Dengue Virus ◽  
Dengue Fever ◽  
Dengue Infection ◽  
Severe Form ◽  
Dengue Haemorrhagic Fever ◽  
Neurological Involvement ◽  
Haemorrhagic Fever ◽  
Dengue Virus Infection

The aim of this study was to describe the frequency and features of headache among patients with confirmed dengue virus infection and to compare the headache features in patients with dengue fever and dengue haemorrhagic fever, primary and secondary dengue infection, and patients with and without neurological involvement. Patients with classic dengue fever had a more intense headache than those with the more severe form of the disease, dengue haemorrhagic fever.

Role of T cells, cytokines and antibody in dengue fever and dengue haemorrhagic fever

2006 ◽  
Vol 16 (4) ◽  
pp. 263-275 ◽  
Author(s):  
Joshua Fink ◽  
Feng Gu ◽  
Subhash G. Vasudevan
Keyword(s):  
T Cells ◽  
Dengue Fever ◽  
Dengue Haemorrhagic Fever ◽  
Haemorrhagic Fever

scholarly journals Trends of fluid requirement in dengue fever and dengue haemorrhagic fever: a single centre experience in Sri Lanka

2015 ◽  
Vol 8 (1) ◽  
Author(s):  
Senanayake AM Kularatne ◽  
Kosala GAD Weerakoon ◽  
Ruwan Munasinghe ◽  
Udaya K Ralapanawa ◽  
Manoji Pathirage
Keyword(s):  
Sri Lanka ◽  
Dengue Fever ◽  
Dengue Haemorrhagic Fever ◽  
Haemorrhagic Fever ◽  
Single Centre ◽  
Single Centre Experience ◽  
Fluid Requirement

A novel dengue fever (DF) and dengue haemorrhagic fever (DHF) analysis using artificial neural network (ANN)

2005 ◽  
Vol 79 (3) ◽  
pp. 273-281 ◽  
Author(s):  
Fatimah Ibrahim ◽  
Mohd Nasir Taib ◽  
Wan Abu Bakar Wan Abas ◽  
Chan Chong Guan ◽  
Saadiah Sulaiman
Keyword(s):  
Neural Network ◽  
Artificial Neural Network ◽  
Dengue Fever ◽  
Dengue Haemorrhagic Fever ◽  
Haemorrhagic Fever ◽  
Artificial Neural ◽  
Artificial Neural Network Ann

scholarly journals Effect of Prior Symptomatic Dengue Infection on Dengue Haemorrhagic Fever (DHF) in Children

2021 ◽  
Vol 2021 ◽  
pp. 1-5
Author(s):  
Randula Ranawaka ◽  
Chamara Jayamanne ◽  
Kavinda Dayasiri ◽  
Dinuka Samaranayake ◽  
Udara Sandakelum ◽  
...  
Keyword(s):  
Dengue Fever ◽  
Past History ◽  
Secondary Infection ◽  
Severe Disease ◽  
Dengue Infection ◽  
Dengue Shock Syndrome ◽  
Dengue Haemorrhagic Fever ◽  
Severe Dengue ◽  
Haemorrhagic Fever ◽  
History Of

Pathogenesis of dengue haemorrhagic fever is not fully understood, but it is thought that there is antibody enhancement during the secondary infection, which causes severe dengue haemorrhagic fever (DHF). Therefore, patients who have DHF should have a documented history of symptomatic dengue infection in the past. A retrospective descriptive-analytical study was conducted at the University Paediatric Unit at Lady Ridgeway Hospital for Children, Colombo, Sri Lanka. All children who had fulfilled the criteria for DHF admitted to the unit from April 2018 to September 2018 were recruited into the study. Relevant data were collected from bed head tickets. One hundred and eighty-four children were included in the final analysis. Thirty-three (17.9%) had a past history of documented symptomatic dengue infection, while 82.1% did not have a documented dengue infection. Twelve patients had dengue shock syndrome, and none of them had previously documented symptomatic dengue fever. Dextran was used in 96 patients in the critical phase. Twelve (42%) patients with past documented symptomatic dengue fever needed dextran while 84 (54.9%) patients without a documented past history of dengue fever needed dextran. In our clinical observation, we noticed that children with DHF mostly did not have a documented symptomatic prior dengue infection, while those with a documented symptomatic prior infection had a milder subsequent illness. In fact, the majority (82.1%) of patients with DHF did not have documented previous symptomatic dengue infection. It was also observed that the clinical course of subsequent dengue infection was less severe in patients with previously documented symptomatic dengue fever. This finding should be further evaluated in a larger scale study minimizing the all-confounding factors. This fact is more important in selecting recipients for vaccines against the dengue virus, which are supposed to produce immunity against the virus without causing the severe disease.

Sign in / Sign up

Export Citation Format

Share Document